当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura
The New England Journal of Medicine ( IF 158.5 ) Pub Date : 2024-05-09 , DOI: 10.1056/nejmoa2402567
Pavan K. Bendapudi 1 , Brody H. Foy 1 , Sarah B. Mueller 1 , Jun Liu 1 , Louis M. Feingold 1 , Kristen E. Burke 1 , Wendy Cruz 1 , Maria Y. Chen 1 , Emily S. Lau 1 , Rachel L. Goldberg 1 , Ishan Tatake 1 , Shelby C. Wilkinson 1 , Brian J. Carney 1 , James R. Stone 1 , Doyun Park 1 , Alzira R. Avelino 1 , Sajjad Hassan 1 , Chester Andrzejewski 1 , Kristen N. Ruby 1 , Kenneth D. Friedman 1 , Patricia A.R. Brunker 1 , Rebecca K. Leaf 1 , John Higgins 1 , Walter H. Dzik 1 , Jonathan A. Stefely 1 , Robert S. Makar 1
Affiliation  

In patients with immune thrombotic thrombocytopenic purpura (iTTP), autoantibodies against the metalloprotease ADAMTS13 lead to catastrophic microvascular thrombosis. However, the potential benefit...

中文翻译:

重组 ADAMTS13 治疗免疫性血栓性血小板减少性紫癜

在免疫性血栓性血小板减少性紫癜 (iTTP) 患者中,针对金属蛋白酶 ADAMTS13 的自身抗体会导致灾难性的微血管血栓形成。然而,潜在的好处...
更新日期:2024-05-09
down
wechat
bug